img

Global In Situ Hybridization Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034


Published on: 2024-01-04 | No of Pages : 411 | Industry : Medical Care

Publisher : GRD Survey | Format : PDF

Global In Situ Hybridization Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034

Executive Summary

According to GRD Survey data, the global In Situ Hybridization market is estimated at 550 million US$ in 2021 and is expected to 710 million US$ by the end of 2028, growing at a CAGR of 3.7% in the forecast period from 2022 to 2028.

This report studies the In Situ Hybridization market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of In Situ Hybridization in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Fluorescence In Situ Hybridization (FISH)
Chromogenic In Situ Hybridization

Market Snapshot, By Application
Cancer Diagnosis
Immunology
Neuroscience
Cytology
Infectious Diseases

Main Market Players Analyzed in this report, including
Thermo Fisher Scientific
Roche
Perkin Elmer
Merck
Exiqon
Danaher
Biogenex Laboratories
Bio Sb
Agilent Technologies
Advanced Cell Diagnostics
Abbott Laboratories

The study objectives of this report are
To study and analyze the global In Situ Hybridization market size (Million USD) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of In Situ Hybridization market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global In Situ Hybridization manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the In Situ Hybridization market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of In Situ Hybridization submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of In Situ Hybridization are as follows
History Year2016-2020
Base Year2020
Estimated Year2021
Forecast Year 2021 to 2027

This report includes the estimation of market size from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Content

Global In Situ Hybridization Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028.pdf

List of Figure

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 In Situ Hybridization Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global In Situ Hybridization Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and In Situ Hybridization

3 3 Industrial Lift Cycle and Main Buyers Analysis
3.1 Industry Life Cycle Analysis
3.2 Key Buying Industries/Consumers
3.2.1 Major Buyers in Cancer Diagnosis
3.2.2 Major Buyers in Immunology

4 Market Segment: by Type
4.1 In Situ Hybridization Type Introduction
4.1.1 Fluorescence In Situ Hybridization (FISH)
4.1.2 Chromogenic In Situ Hybridization
4.2 Global In Situ Hybridization Revenue by Type 2016-2021

5 Market Segment: by Application
5.1 In Situ Hybridization Type Introduction
5.1.1 Cancer Diagnosis
5.1.2 Immunology
5.1.3 Neuroscience
5.1.3 Cytology
5.1.4 Infectious Diseases
5.2 Global In Situ Hybridization Revenue by Application 2016-2021

6 Marke Segment: by Region
6.1 Global In Situ Hybridization Market by Region
6.2 North America In Situ Hybridization Market 2016-2021
6.3 Europe In Situ Hybridization Market 2016-2021
6.4 Asia Pacific In Situ Hybridization Market 2016-2021
6.5 South America In Situ Hybridization Market 2016-2021
6.6 Middle East and Africa In Situ Hybridization Market 2016-2021

7 North America
7.1 North America In Situ Hybridization Market by Country 2016-2021
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe In Situ Hybridization Market by Country 2016-2021
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific In Situ Hybridization Market by Country 2016-2021
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America In Situ Hybridization Market by Country 2016-2021
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa In Situ Hybridization Market by Country 2016-2021
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Thermo Fisher Scientific
12.1.1 Thermo Fisher Scientific Company Information
12.1.2 Thermo Fisher Scientific In Situ Hybridization Product Portfolio, Specification and Application
12.1.3 Thermo Fisher Scientific In Situ Hybridization Revenue and Gross Margin (2019-2021)
12.1.4 Thermo Fisher Scientific Key Development
12.2 Roche
12.2.1 Roche Company Information
12.2.2 Roche In Situ Hybridization Product Portfolio, Specification and Application
12.2.3 Roche In Situ Hybridization Revenue and Gross Margin (2019-2021)
12.2.4 Roche Key Development
12.3 Perkin Elmer
12.3.1 Perkin Elmer Company Information
12.3.2 Perkin Elmer In Situ Hybridization Product Portfolio, Specification and Application
12.3.3 Perkin Elmer In Situ Hybridization Revenue and Gross Margin (2019-2021)
12.3.4 Perkin Elmer Key Development
12.4 Merck
12.4.1 Merck Company Information
12.4.2 Merck In Situ Hybridization Product Portfolio, Specification and Application
12.4.3 Merck In Situ Hybridization Revenue and Gross Margin (2019-2021)
12.4.4 Merck Key Development
12.5 Exiqon
12.5.1 Exiqon Company Information
12.5.2 Exiqon In Situ Hybridization Product Portfolio, Specification and Application
12.5.3 Exiqon In Situ Hybridization Revenue and Gross Margin (2019-2021)
12.5.4 Exiqon Key Development
12.6 Danaher
12.6.1 Danaher Company Information
12.6.2 Danaher In Situ Hybridization Product Portfolio, Specification and Application
12.6.3 Danaher In Situ Hybridization Revenue and Gross Margin (2019-2021)
12.6.4 Danaher Key Development
12.7 Biogenex Laboratories
12.7.1 Biogenex Laboratories Company Information
12.7.2 Biogenex Laboratories In Situ Hybridization Product Portfolio, Specification and Application
12.7.3 Biogenex Laboratories In Situ Hybridization Revenue and Gross Margin (2019-2021)
12.7.4 Danaher Key Development
12.9 Agilent Technologies
12.9.1 Agilent Technologies Company Information
12.9.2 Agilent Technologies In Situ Hybridization Product Portfolio, Specification and Application
12.9.3 Agilent Technologies In Situ Hybridization Revenue and Gross Margin (2019-2021)
12.9.4 Agilent Technologies Key Development
12.8 Bio Sb
12.8.1 Bio Sb Company Information
12.8.2 Bio Sb In Situ Hybridization Product Portfolio, Specification and Application
12.8.3 Bio Sb In Situ Hybridization Revenue and Gross Margin (2019-2021)
12.8.4 Bio Sb Key Development
12.11 Abbott Laboratories
12.11.1 Abbott Laboratories Company Information
12.11.2 Abbott Laboratories In Situ Hybridization Product Portfolio, Specification and Application
12.11.3 Abbott Laboratories In Situ Hybridization Revenue and Gross Margin (2019-2021)
12.11.4 Abbott Laboratories Key Development

13 Global In Situ Hybridization Market Forecast by Region by Type and by Application
13.1 Global In Situ Hybridization Revenue Forecast 2022-2027
13.2 Global In Situ Hybridization Forecast by Regions
13.3 Global In Situ Hybridization Forecast by Type
13.4 Global In Situ Hybridization Forecast by Application

14 Analyst Views and Conclusions

15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer